EVC
CVS icon

Eidelman Virant Capital’s CVS Health CVS Stock Holding History

Eidelman Virant Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.78M Hold
18,425
– – 1.31% 19
2022
Q2 		$1.74M Sell
18,425
-1,000
-5% -$97.6K 1.25% 19
2022
Q1 		$1.97M Sell
19,425
-19,430
-50% -$2.04M 1.06% 26
2021
Q4 		$4.02M Sell
38,855
-785
-2% -$72.5K 1.46% 18
2021
Q3 		$3.4M Sell
39,640
-280
-0.7% -$23.5K 1.3% 22
2021
Q2 		$3.33M Sell
39,920
-2,560
-6% -$210K 1.28% 24
2021
Q1 		$3.17M Sell
42,480
-13,875
-25% -$1.01M 1.28% 25
2020
Q4 		$3.85M Buy
56,355
+10,750
+24% +$699K 1.68% 13
2020
Q3 		$2.63M Sell
45,605
-7,750
-15% -$482K 1.45% 17
2020
Q2 		$3.47M Buy
53,355
+2,540
+5% +$160K 2.43% 10
2020
Q1 		$3.02M Buy
50,815
+1,338
+3% +$89.3K 3.13% 7
2019
Q4 		$3.68M Buy
49,477
+5,900
+14% +$414K 1.8% 11
2019
Q3 		$2.75M Buy
43,577
+7,800
+22% +$462K 1.58% 14
2019
Q2 		$1.95M Buy
35,777
+2,500
+8% +$135K 1.03% 25
2019
Q1 		$1.79M Buy
33,277
+13,225
+66% +$816K 1.26% 25
2018
Q4 		$1.31M Buy
+20,052
New +$1.5M 0.99% 33
2016
Q4 		– Sell
-2,670
Closed -$237K – 125
2016
Q3 		$237K Buy
2,670
+500
+23% +$47.2K 0.15% 99
2016
Q2 		$208K Sell
2,170
-355
-14% -$35.4K 0.13% 111
2016
Q1 		$263K Hold
2,525
– – 0.18% 94
2015
Q4 		$246K Buy
+2,525
New +$247K 0.15% 114
2015
Q3 		– Sell
-2,500
Closed -$262K – 146
2015
Q2 		$262K Hold
2,500
– – 0.12% 123
2015
Q1 		$258K Hold
2,500
– – 0.11% 129
2014
Q4 		$241K Buy
+2,500
New +$220K 0.11% 126

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eidelman Virant Capital's CVS Position: Q3 2022 in Review

Eidelman Virant Capital held its CVS Health (CVS) position steady in Q3 2022 at 18,425 shares worth $1.78M. The position accounts for 1.31% of the portfolio, ranked #19.

Eidelman Virant Capital first reported a position in CVS in Q4 2014 and has held it in 23 quarters since. The position peaked at $4.02M in Q4 2021. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Eidelman Virant Capital held 18,425 shares of CVS Health worth $1.78M as of Q3 2022.
  • Eidelman Virant Capital left its CVS Health share count unchanged in Q3 2022.
  • CVS Health made up 1.31% of Eidelman Virant Capital's portfolio in Q3 2022, its #19 holding.
  • Eidelman Virant Capital first reported a position in CVS Health in Q4 2014 and has held it in 23 quarters since.
  • Eidelman Virant Capital's CVS Health position peaked at $4.02M in Q4 2021.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Eidelman Virant Capital's 13F filing for Q3 2022, filed 25 Oct 2022.